Jun signaling has been shown to contribute to lymphoma growth and dissemination to extra-nodal sites, highlighting the potential of PI3K inhibitors to impede several key pathways important for DLBCL survival and dissemination [42]. This evidence concerns the gene PIK3CB and diffuse large B-cell lymphoma.